Immunovant files prospectus supplement to register 5.65M shares for resale by selling stockholders

Immunovant, Inc.

Filed prospectus supplement to register up to 5,654,990 shares of common stock for resale by selling stockholders.
Shares were acquired by selling stockholders in private placement financing reported on January 13, 2025.
Opinion of counsel Cooley LLP regarding legality of shares filed as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.